Reactivity to AQP4 epitopes in relapsing-remitting multiple sclerosis

Area of Science:

• Neuroimmunology
• Autoimmunity
• Astrocytic biology

Background:

• Autoantibodies targeting aquaporin-4 (AQP4), a water channel predominantly in central nervous system astrocytes, are key in Devic's disease (Neuromyelitis Optica Spectrum Disorder).
• Investigating AQP4 epitope recognition in Multiple Sclerosis (MS) may reveal distinct disease subsets and shared pathogenic mechanisms with Neuromyelitis Optica (NMO).

Purpose of the Study:

• To determine if Multiple Sclerosis (MS) patients recognize specific antigenic epitopes on aquaporin-4 (AQP4).
• To explore potential links between MS disease subsets and Neuromyelitis Optica (NMO) pathogenesis through AQP4 autoimmunity.

Main Methods:

• Sera from 45 relapsing-remitting MS (RRMS), 13 primary progressive MS (PMS) patients, and control groups (NMO, Systemic Lupus Erythematosus, Sjogren syndrome, healthy individuals) were screened.
• A cell-based assay was used to detect antibodies against the intracellular AQP4 epitope AQPaa252-275.

Main Results:

• NMO patient sera confirmed reactivity to the AQPaa252-275 epitope.
• While most RRMS sera tested negative, 13% unexpectedly reacted with the AQPaa252-275 epitope.
• PMS patients and all control groups showed no specific reactivity to the tested AQP4 epitope.

Conclusions:

• A subset of RRMS patients exhibits reactivity to the AQP4 epitope targeted in NMO, suggesting potential convergent pathogenic pathways.
• Further research is needed to ascertain if these AQP4 autoantibodies define distinct MS subsets or are merely markers of astrocytic damage.